---
layout: post
title: "$207B Market Shift: The Race for Fast Track Approval in Oncology"
date: 2026-02-05T14:35:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/207b-market-shift-the-race-for-fast-track-approval-in-oncology-302680332.html
significance: 8.00
---

<p>Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 5, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary â€“ The FDA isn't just approving drugs; they are completely reshaping the landscape. In 2025 alone, the agency issued over 50 oncology approvals[1], but the real story is...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/207b-market-shift-the-race-for-fast-track-approval-in-oncology-302680332.html)

**Published:** 2026-02-05 14:35:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/207b-market-shift-the-race-for-fast-track-approval-in-oncology-302680332.html)
